Outcomes of SOT Recipients With COVID-19 in Different Eras of COVID-19 Therapeutics

BACKGROUND. Few reports have focused on newer coronavirus disease 2019 (COVID-19) therapies (remdesivir, dexamethasone, and convalescent plasma) in solid organ transplant recipients; concerns had been raised regarding possible adverse impact on allograft function or secondary infections. METHODS. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Sait, Afrah S., Chiang, Teresa Po-Yu, Marr, Kieren A., Massie, Allan B., Cochran, Willa, Shah, Pali, Brennan, Daniel C., Thomas, Alvin G., Mehta Steinke, Seema, Permpalung, Nitipong, Shoham, Shmuel, Merlo, Christian, Jain, Tania, Boyarsky, Brian, Charnaya, Olga, Gurakar, Ahmet, Sharma, Kavita, Durand, Christine M., Werbel, William A., Huang, Chiung-Yu, Ostrander, Darin, Desai, Niraj, Kim, Min Young, Alasfar, Sami, Bloch, Evan M., Tobian, Aaron A.R., Garonzik-Wang, Jacqueline, Segev, Dorry L., Avery, Robin K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710330/
https://www.ncbi.nlm.nih.gov/pubmed/34966840
http://dx.doi.org/10.1097/TXD.0000000000001268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710330/
https://www.ncbi.nlm.nih.gov/pubmed/34966840
http://dx.doi.org/10.1097/TXD.0000000000001268

Ejemplares similares